Cargando…
Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case report
BACKGROUND: Long-term survival after resection of metastases from pancreatic ductal adenocarcinoma is rare. CASE PRESENTATION: A 54-year-old man underwent pancreaticoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC) with UICC staging pT3N1M0 followed by adjuvant chemotherapy with gemcita...
Autores principales: | Matsuki, Ryota, Sugiyama, Masanori, Takei, Hidefumi, Kondo, Haruhiko, Fujiwara, Masachika, Shibahara, Junji, Furuse, Junji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871609/ https://www.ncbi.nlm.nih.gov/pubmed/29589221 http://dx.doi.org/10.1186/s40792-018-0435-2 |
Ejemplares similares
-
A Prospective Study of Neoadjuvant Gemcitabine Plus Nab-paclitaxel in Patients with Borderline-resectable Pancreatic Cancer
por: Okano, Naohiro, et al.
Publicado: (2022) -
Essential updates 2021/2022: Surgical outcomes of oligometastasis in pancreatic ductal adenocarcinoma
por: Yasuda, Satoshi, et al.
Publicado: (2023) -
Successful treatment of induced oligometastasis and repeated oligoprogression of advanced lung adenocarcinoma with immunotherapy and radiotherapy
por: Lee, Ho Young, et al.
Publicado: (2022) -
Diagnosis of oligometastasis
por: Terao, Mayako, et al.
Publicado: (2020) -
Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
por: Ei, Shigenori, et al.
Publicado: (2023)